Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04691960
Status:
RECRUITING
Last Update Posted:
2023-09-14
First Post:
2020-12-30
Brief Title:
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma Feasibility and Metabolic Imaging
Sponsor:
Weill Medical College of Cornell University
Organization:
Weill Medical College of Cornell University
Study Overview
Official Title:
A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma Feasibility and Metabolic Imaging
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This clinical trial is for men and women with high-grade gliomas Glucose sugar is thought to be a contributor to tumor growth The ketogenic diet a high fat low carbohydrate diet and metformin a drug approved by the Food and Drug Administration to treat type 2 diabetes are both known to lower blood glucose levels The purpose of the study is to evaluate the tolerability of a ketogenic diet in conjunction with metformin and whether maintaining and the diet with metformin will have any effect on participants Participants will prepare their own meals with the help of a nutritionist Participants will continue on treatment as long as they are responding to therapy and not experiencing unacceptable side effects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None